(Q38892348)

7 September 2017

Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta, Egypt (English)

1 reference

7 September 2017

0 references

1 reference

1 reference

1 reference

Rashida Barakat

1

1 reference

PubMed ID

21078223

7 September 2017

Hala El Morshedy

series ordinal

2

1 reference

7 September 2017

16 November 2010

1 reference

7 September 2017

1 reference

7 September 2017

138

1 reference

7 September 2017

4

1 reference

7 September 2017

440-446

1 reference

Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis

7 September 2017

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

Field trials of praziquantel and oxamniquine for the treatment of schistosomiasis mansoni in Burundi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

The global status of schistosomiasis and its control

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

Drugs for the control of parasitic diseases: current status and development in schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

Praziquantel side effects and efficacy related to Schistosoma mansoni egg loads and morbidity in primary school children in north-east Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

Schistosoma mansoni: chemotherapy of infections of different ages

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

An international initiative on praziquantel use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

A quantitative analysis of the diagnostic value of diethylcarbamazine provocation in endemic Wuchereria bancrofti infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

7 January 2021

Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

7 January 2021

IN VITRO CULTIVATION OF SCHISTOSOMA MANSONI

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

7 January 2021

Day-to-day egg count fluctuation in Schistosoma mansoni infection and its operational implications

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

7 January 2021

Use of praziquantel against schistosomiasis: a review of current status.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

7 January 2021

Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

7 January 2021

Quick Kato smear for field quantification of Schistosoma mansoni eggs

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

7 January 2021

Efficacy of praziquantel against Schistosoma mansoni in northern Senegal

1 reference

https://api.crossref.org/works/10.1017%2FS003118201000154X

7 January 2021

10.1017/S003118201000154X

Identifiers

DOI

1 reference

7 September 2017

1 reference

PubMed ID

21078223